United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$316.89 USD
+2.33 (0.74%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $316.92 +0.03 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 6.18 |
EPS Last Quarter | 6.17 |
Last EPS Surprise | 9.59% |
ABR | 1.54 |
Earnings ESP
|
4.91% |
---|---|
Current Year | 24.73 |
Next Year | 27.16 |
EPS (TTM) | 21.15 |
P/E (F1) | 12.72 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 682.11M | 696.51M | 2.71B | 2.85B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 701.50M | 734.00M | 2.84B | 3.16B |
Low Estimate | 652.07M | 639.06M | 2.59B | 2.62B |
Year ago Sales | 596.50M | 609.40M | 2.33B | 2.71B |
Year over Year Growth Est. | 14.35% | 14.29% | 16.46% | 5.16% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.18 | 6.49 | 24.73 | 27.16 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | 6.00 | 5.99 | 23.25 | 21.75 |
High Estimate | 6.49 | 7.37 | 28.89 | 37.65 |
Low Estimate | 5.67 | 5.61 | 22.25 | 21.67 |
Year ago EPS | 5.24 | 5.38 | 19.81 | 24.73 |
Year over Year Growth Est. | 17.94% | 20.63% | 24.84% | 9.82% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 6.18 | 6.49 | 24.73 | 27.16 |
7 Days Ago | 6.18 | 6.49 | 24.73 | 27.16 |
30 Days Ago | 6.12 | 6.49 | 24.48 | 26.81 |
60 Days Ago | 6.13 | 6.21 | 24.20 | 26.74 |
90 Days Ago | 5.85 | 6.10 | 23.46 | 24.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 6.49 | 6.56 | 25.20 | 27.00 |
Zacks Consensus Estimate | 6.18 | 6.49 | 24.73 | 27.16 |
Earnings ESP | 4.91% | 1.05% | 1.88% | -0.60% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 6.17 | 4.36 | 5.38 | 5.24 | NA |
Estimate | 5.63 | 3.92 | 4.89 | 4.41 | NA |
Difference | 0.54 | 0.44 | 0.49 | 0.83 | 0.58 |
Surprise | 9.59% | 11.22% | 10.02% | 18.82% | 12.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more